Four tachykinin (NK2) receptor inhibitors, SCH 378161 (1), SCH 217048 (2), SCH 378199 (3), and SCH 378167 (4) were isolated from the fermentation broth of a taxonomically unidentified fungus. These compounds were separated from the fermentation broth by ethyl acetate extraction. Purification and separation of the individual compoundswere achieved by NK2assay-guided fractionation using gel filtration, reverse phase chromatography and HPLC. They were identified to be a family of depsipeptides by spectroscopic and degradation studies. Compounds1 and 3 contain proline and differ as an amide and acid whereas 2 and 4 contain pipecolic acid and differ in being an amide and acid. All of these compoundscontain an identical hydroxy acid. They are selective NK2 inhibitors with Ki values ranging from 27-982nM and demonstrate no activity at IO^m in the NKj and NK3assays. In addition, compounds 1 and 2 inhibited NKA-induced increases in the concentration of intracellular Ca2+, [Ca2+]j, in a CHOcell expressing the human NK2 receptor; this inhibition was competitive in nature with pA2 values of 7.2 and 7.5, respectively. These data demonstrate that these natural products are selective and competitive receptor antagonists of the humanNK2receptor.
378199 (3), and SCH 378167 (4) were isolated from the fermentation broth of a taxonomically unidentified fungus. These compounds were separated from the fermentation broth by ethyl acetate extraction. Purification and separation of the individual compoundswere achieved by NK2assay-guided fractionation using gel filtration, reverse phase chromatography and HPLC. They were identified to be a family of depsipeptides by spectroscopic and degradation studies. Compounds1 and 3 contain proline and differ as an amide and acid whereas 2 and 4 contain pipecolic acid and differ in being an amide and acid. All of these compoundscontain an identical hydroxy acid. They are selective NK2 inhibitors with Ki values ranging from 27-982nM and demonstrate no activity at IO^m in the NKj and NK3assays. In addition, compounds 1 and 2 inhibited NKA-induced increases in the concentration of intracellular Ca2+, [Ca2+]j, in a CHOcell expressing the human NK2 receptor; this inhibition was competitive in nature with pA2 values of 7.2 and 7.5, respectively. These data demonstrate that these natural products are selective and competitive receptor antagonists of the humanNK2receptor.
The tachykinin peptides present in mammaliansystems include substance P (Sub. P), neurokinin A (NKA) and neurokinin B (NKB). These structurally related peptides share a commoncarboxyl-terminal sequence, Phe-X-GlyLeu-Met-NH21}. Tachykinins are located in sensory neurons in both the peripheral and central nervous systems2). Upon stimulation of C-fibres, these peptides are released and exert their biological effects through specific receptors designated as NK1? NK2 and NK3. Sub. P preferentially binds to the NKj receptor, NKAto the NK2receptor, and NKBto the NK3receptor3). Activation of the NK}receptor has been implicated in edema and neurogenic inflammation4 
Materials and Methods
The fungus that produces the active compounds was isolated from mixed litter from a humid forest area near Kandy, Sri Lanka. The microorganism is a fungal culture with sterile, dematiaceous mycellium with low, dry, thin hyphae. Taxonomic evaluation and classification of the fungus producing the neurokinin inhibitors has not been performed.
Fermentation Conditions
Fermentation studies were carried out in shake flasks.
Stock cultures were maintained as frozen whole broths at -80°C in a final concentration of 10% glycerol. The inoculum medium for NK2inhibitor contained (g/liter)
proteus peptone 5, NaCl 5, KH2PO4 5, yeast extract 3, cerelose 20, soybean grits 5, antifoam 1 ml, tap H2O to 1 liter. The pH was adjusted to 7.2 prior to autoclaving. A 250-ml Erlenmeyer flask containing 70 ml of this medium was inoculated with 2.0ml of the stock culture. The flask was incubated at 24°C on a rotary shaker at 250rpmfor 96 hours. Twoand one halfml of this seed culture was used to inoculate another 250 ml Erlenmeyer flask containing 70 ml of the same seed medium. This flask was incubated as above for 96 hours.
Five percent of the second germination was used to inoculate the fermentation medium containing (g/liter) neopeptone (10), cerelose (40), CaCO3 (4), and Tap H2O to 1 liter. The pH was adjusted to 7.4 prior to autoclaving. The fermentation was carried out in 2 liter Erlenmeyer flasks containing 350 ml of the fermentation medium. The flasks were incubated at 24°C on a rotary shaker at 250rpmfor 120 hours.
Fermentation Analysis
Production of the neurokinin receptor inhibitors was monitored over time by NK2binding assays.
Isolation
The steps leading to isolation and purification of the neurokinin receptor inhibitors are shown in Figure 1 . Four liters of fermentation broth was extracted with two volumes of ethyl acetate twice, the organic layer was removed from the broth, dried over anhydrous sodium sulfate and the solvent was removed to yield 1.2g of organic extract. The extract was dissolved in a minimumamountof methanol and loaded on a Sephadex LH-20 column packed in methanol. The column was eluted with methanol and the fractions were monitored by the NK2 receptor binding assay. The active fractions were combined and the solvent removed to yield 0.6g of solids enriched with NK2 inhibitors. The active compounds were purified on a preparative Deltapak C-18 column eluting with an acetonitrile: 0.05% triflouroacetic acid TFA (35 : 65). The acetonitrile was removed from the individual peak eluates under vacuumand the remaining aqueous solution on freeze drying yielded 15, 100, 0.5, and 0.5 mgs of1, 2, 3 and 4 respectively.
Physico-chemical Properties
The physico-chemical properties of the neurokinin receptor inhibitors 1-4 are summarized in the experimental section. As compound 2 was produced in large quantity, this was used for structural elucidation purposes. The structure of this compound is published elsewhere.8) All compounds were isolated as amorphous white powders. These compounds showed only end absorption in UVspectrum. The amino acid residues were identified by acid hydrolysis, with 6 n HC1 and subsequent TLCanalysis of the hydrolysis products. 
Results
Production of the neurokinin inhibitors in fermentation was monitored using ethyl acetate extracts of the aliquots obtained at different times during the fermentation process. The production of neurokinin inhibitors in the fermentation peaked at 120 hours.
The ethyl acetate extract provided four tachykinin (NK2) inhibitors that were similar in nature. They were further purified and separated by using reverse phase c hromatog raphy. The Ki values for compounds 1-4 in NK1? NK2 and NK3 receptor binding assays are shown in Table 2 Figure  6A and B). In the presence of increasing concentrations of compound 1 or 2, the NKA response curves shift to the right in a parallel fashion with no decrease in the maximumresponse ( Figure 6A and B ). These data demonstrate that compound 1 and 2 are functional antagonists of the human NK2receptor. Schild analysis of the data demonstrates a competitive antagonism with pA2 values of 7.2 and 7.5 for compounds 1 and 2, respectively ( Figure 6C and D) .
Conclusion
Compounds2 and 4 containing pipecolic acid are about two-fold more active than compounds1 and 3 containing proline. Also compound 1 and 2 containing A/-methyl glutamine are about eight-fold more active than compounds 3 and 4 containing Af-methyl glutamic acid. All of these compounds exhibited no inhibition against NKj and NK3 receptors.
There is substantial evidence that activation of NK2and NK2 receptors is an important step in a variety of physiologic responses including pain transmission, smooth Hydrolysis of 1: SCH 378161 (1) (5mg) was dissolved in 2ml of6n HC1 and the solution was heated at 95°C for 20 hours. The solution was diluted with water and lyophilized and the solids obtained were dissolved in 0.5 ml water, which was used for amino acid analysis9). 
